logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Share:
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for cytx
Joey Joe Joe Junior
22 Dec 14 20:17:04
watchlist for Dec. 23rd... $GACR $BLUU $EPXY $WTSL $CGRW $CYTX $QTM $BTX $MCHX
FRAN BENEDITO
22 Dec 14 13:05:10
RT @AnalystWire: Increased BARDA Funding a Validation for Cytori $CYTX ADRC Celution System, Maxim Group Says http://t.co/9mn6qT1gTG
UndervaluedBioStocks
22 Dec 14 12:59:52
$CYTX still in accumulation mode this week? Will have its day soon.
Small Cap Trader
22 Dec 14 08:50:22
RT @ProVesting: $CYTX: Cytori Therapeutics Given a $6.00 Price Target by Maxim Group ... http://t.co/hG0OE5UjAX http://t.co/7pO5LvGHtz
Small Cap Trader
22 Dec 14 08:49:03
$CYTX daily with potential
OCMillionare
22 Dec 14 08:19:26
$CANF and $CYTX both turning around
Trading-Pennies
22 Dec 14 07:59:53
$CYTX of interest
Captain Sequence
22 Dec 14 06:32:14
RT @bkfViking123: $cytx clear sailing to the 200 day http://t.co/wA5MhvMiSH
Niko
22 Dec 14 06:07:01
Holding long $CYTX on $2 million contract news as well as $6.00 PT
mike lipari
22 Dec 14 06:02:50
$CYTX pre market going up
Niko
22 Dec 14 05:56:30
$CYTX $2 million contract option for thermal burn treatment research http://t.co/XLXV7gHquv via @BioPrepWatch1
Captain Sequence
22 Dec 14 05:30:27
$CYTX amends contract with US department of health human service's biomedical advanced research and dev authority NET INCREASE OF APPROX $2M
Captain Sequence
22 Dec 14 05:28:27
RT @StockNews_: $CYTX - Current Report Filing (8-k) http://t.co/SxyoEbvzUY
Captain Sequence
22 Dec 14 05:28:13
RT @MarketCurrents: Cytori and BARDA amend contract for development of thermal burn cell therapy http://t.co/UA4yzuBQkD #premarket $CYTX
ProTradersNews
22 Dec 14 05:23:04
$CYTX $ALNY: Investor Choice: Cytori Therapeutics, Inc. (NASDAQ:CYTX ... http://t.co/xxgH1BAU6U http://t.co/JItHLqv5wN
ProVesting
22 Dec 14 04:53:07
$CYTX: Cytori and BARDA amend contract for development of thermal burn ... http://t.co/cCUUSSd74S http://t.co/XiOspChGWc
MarketCurrents
22 Dec 14 04:45:41
Cytori and BARDA amend contract for development of thermal burn cell therapy http://t.co/UA4yzuBQkD #premarket $CYTX
ISAAC ALEX
22 Dec 14 04:07:53
RT @ProVesting: $CYTX: Cytori Therapeutics Given a $6.00 Price Target by Maxim Group ... http://t.co/hG0OE5UjAX http://t.co/7pO5LvGHtz
StockNews
22 Dec 14 03:20:18
$CYTX - Current Report Filing (8-k) http://t.co/SxyoEbvzUY
NASDAQ
22 Dec 14 03:20:13
$CYTX - Current Report Filing (8-k) http://t.co/qk6c3JcD8J
Pzaa...Guy
22 Dec 14 03:20:08
$CYTX - Current Report Filing (8-k) http://t.co/IqrOhonFKk
Stocks News&Markets
22 Dec 14 03:20:06
$CYTX - Current Report Filing (8-k) http://t.co/dNlAJitv1k
$Stocknewsalerts
22 Dec 14 03:17:33
$CYTX Cytori - 8-K (Current report filing) SEC Filing From our Stock News Alerts App
Captain Sequence
22 Dec 14 03:12:57
RT @bkfViking123: good news for $cytx http://t.co/nASKYg8Ma6
Breaking News
22 Dec 14 03:02:02
$CYTX: Cytori Therapeutics Inc Files a New Report with the SEC: http://t.co/Y3edYWEM9U http://t.co/bMphoKcor9
ProVesting
22 Dec 14 02:06:02
$CYTX: Cytori Therapeutics Given a $6.00 Price Target by Maxim Group ... http://t.co/hG0OE5UjAX http://t.co/7pO5LvGHtz
Bryon Franzen
21 Dec 14 23:48:45
good news for $cytx http://t.co/nASKYg8Ma6
Bryon Franzen
21 Dec 14 23:42:57
$cytx clear sailing to the 200 day http://t.co/wA5MhvMiSH
Trader News Daily
21 Dec 14 21:44:05
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $SFY $GST $HOV $JRJC $ISCO $CYTX
Trader News Daily
21 Dec 14 18:29:03
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $SFY $GST $HOV $JRJC $ISCO $CYTX
heavyd
21 Dec 14 13:27:55
RT @FinSentS_NASDAQ: $CYTX:US Cytori Therapeutics PT Set at $6.00 by Maxim Group #CYTORI THERAPEUTICS INC http://t.co/7GjDBmsLdR #NASDAQ
JacksonT
21 Dec 14 07:11:29
RT @TickerStock: PSW Watchlist Week Of Dec. 22nd 2014 – $RSH $TPLM $GTATQ $ECIG $CYTX $QTM http://t.co/09Qnaejz5N
jonat
21 Dec 14 07:08:13
RT @TickerStock: PSW Watchlist Week Of Dec. 22nd 2014 – $RSH $TPLM $GTATQ $ECIG $CYTX $QTM http://t.co/09Qnaejz5N
StockTicks
21 Dec 14 07:02:43
PSW Watchlist Week Of Dec. 22nd 2014 – $RSH $TPLM $GTATQ $ECIG $CYTX $QTM http://t.co/09Qnaejz5N
FinSentS NASDAQ
20 Dec 14 15:29:12
$CYTX:US Cytori Therapeutics PT Set at $6.00 by Maxim Group #CYTORI THERAPEUTICS INC http://t.co/7GjDBmsLdR #NASDAQ
FinSentS NASDAQ
20 Dec 14 07:28:53
$CYTX:US Cytori Therapeutics PT Set at $6.00 by Maxim Group #CYTORI THERAPEUTICS INC http://t.co/LqEMgEMECC #NASDAQ
PennyStockSuperstar
19 Dec 14 23:43:27
Check out our alert track record here... http://t.co/BdiZMRYWH1. Sign up is free. See you soon! $FNFG $SVU $CYTX $MM $PDS
Greg David
19 Dec 14 23:29:44
I want to give http://t.co/m2LNLuLe8I a shout out. Banked 125% last week thanks to them. You guys rock! $NTRR $CYTX $EXEL $WPRT
FinSentS NASDAQ
19 Dec 14 23:28:32
$CYTX:US Cytori Therapeutics PT Set at $6.00 by Maxim Group #CYTORI THERAPEUTICS INC http://t.co/ZGquQQrUS9 #NASDAQ
ProVesting
19 Dec 14 19:28:06
$CYTX: Cytori Therapeutics PT Set at $6.00 by Maxim Group http://t.co/HLBWm4GR8S http://t.co/2l4o2b84Nr
US Consumer News
19 Dec 14 19:14:54
Cytori Therapeutics given $6.00 PT by Maxim Group. buy rating. http://t.co/jV1y6eKzJl $CYTX #CYTX
Analyst Ratings
19 Dec 14 19:09:29
Cytori Therapeutics given $6.00 PT by Maxim Group. buy rating. http://t.co/to6rpI37mq $CYTX #CYTX
Smarter Analyst
19 Dec 14 15:49:22
$CYTX Maxim Maintains Buy On Cytori As BARDA Increases Contract Funding For Thermal Burns http://t.co/OdT3xEY8uQ
MAISA
19 Dec 14 14:52:30
$CYTX amended option is valued at $14.1 million, an increase of approximately $2 million from its original value of $12.1 million
MAISA
19 Dec 14 14:52:10
$CYTX executed an amendment of a contract option originally signed in August 2014 to fund continued development of Cytori Cell Therapy™
Greg David
19 Dec 14 13:44:26
I want to give http://t.co/m2LNLuLe8I a shout out. Banked 125% last week thanks to them. You guys rock! $NTRR $CYTX $EXEL $WPRT
Time=Best Stock
19 Dec 14 12:39:19
RT @riley4090: $CYTX
Brian Riley
19 Dec 14 12:38:13
$CYTX
heavyd
19 Dec 14 12:33:54
RT @CytoriIR: Cytori will host informational session on STAR pivotal trial w/ Dr. Dinesh Khanna on Jan 14 http://t.co/CuhjYjyBbb $CYTX @SDD…
Cytori IR
19 Dec 14 12:15:01
Cytori will host informational session on STAR pivotal trial w/ Dr. Dinesh Khanna on Jan 14 http://t.co/CuhjYjyBbb $CYTX @SDDT #Scleroderma
				
				
By  +Follow August 1, 2013 8:43AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.